6-chloro-9-(3-methoxyphenylmethyl)-9H-purine | 112088-89-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 咪唑并嘧啶类
• 英文名称: 6-chloro-9-(3-methoxyphenylmethyl)-9H-purine
• 英文别名: 6-Chloro-9-[(3-methoxyphenyl)methyl]purine
• CAS: 112088-89-8
• 化学式: C₁₃H₁₁ClN₄O
• 分子量: 274.71
• InChiKey: DDJMCENRGWXTNB-UHFFFAOYSA-N

物化性质

• 熔点：
  104-105 °C
• 沸点：
  474.6±55.0 °C(Predicted)
• 密度：
  1.39±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  19
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.15
• 拓扑面积：
  52.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-(三丁基锡烷基)呋喃 、 6-chloro-9-(3-methoxyphenylmethyl)-9H-purine 在 bis(triphenylphosphine)palladium(II)-chloride 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 18.0h， 以94%的产率得到6-(2-Furyl)-9-(3-methoxyphenylmethyl)-9H-purine
  参考文献：
  名称：

  Synthesis, Biological Activity, and SAR of Antimycobacterial 9-Aryl-, 9-Arylsulfonyl-, and 9-Benzyl-6-(2-furyl)purines

  摘要：

  9-Aryl-, 9-arylsulfonyl- and 9-benzyl-6-(2-furyl)purines were synthesized by N-alkylation or N-arylation of the purine followed by Stille coupling to introduce the faryl substituent in the 6-position and the compounds screened for activity against Mycobacterium tuberculosis. The 9-aryl- and 9-sulfonylarylpurines exhibited weak activity toward the bacteria, but 9-benzylpurines were good inhibitors especially those carrying electron-donating substituents on the phenyl ring. A chlorine atom in the purine 2-position further enhanced activity. The high antimycobacterial activity (MIC 0.39,mu g/mL against M. tuberculosis), low toxicity against mammalian cells and activity inside macrophages found for 2-chloro-6-(2-furyl)-9-(4-methoxyphenylmethyl)9H-purine makes this compound a highly interesting potential antituberculosis drug.

  DOI：

  10.1021/jm0408924
• 作为产物：
  描述：

  3-甲氧基苄胺 在 乙基磺酸 、 三乙胺 作用下， 以 正丁醇 为溶剂， 反应 62.0h， 生成 6-chloro-9-(3-methoxyphenylmethyl)-9H-purine
  参考文献：
  名称：

  6-（烷基氨基）-9-苄基-9H-嘌呤。一类新的抗惊厥药。

  摘要：

  合成了几种9-烷基-6-取代的嘌呤，并测试了其对大鼠最大电击诱发的癫痫发作（MES）的抗惊厥活性。大多数化合物是从3-氨基-4,6-二氯嘧啶分三步制备的，也可以通过6-氯嘌呤的烷基化分两步制备的。针对MES的有效的抗惊厥活性存在于在6-（甲基氨基）-或6-（二甲基-氨基）嘌呤的9位上含有苄基取代基的化合物中。在控制癫痫发作的常用药物中，这种类型的结构代表了一类新型的强效惊厥药物。

  DOI：

  10.1021/jm00398a019

文献信息

• Purine compounds
  申请人：Gundersen Lise-Lotte

  公开号：US20070203159A1

  公开（公告）日：2007-08-30

  The invention provides an antimycobacterial 6-aryl-9-(m- or p-substituted-benzyl) purine and purine analog compounds.

  这项发明提供了一种抗分枝杆菌的6-芳基-9-(m-或p-取代苄基)嘌呤和嘌呤类似化合物。
• Synthesis of 8-Bromo-<i>N</i>-benzylpurines via 8-Lithiated Purines: Scope and Limitations
  作者：Thywill Gamadeku、Lise-Lotte Gundersen

  DOI：10.1080/00397910903318708

  日期：2010.8.16

  9-Benzylpurines have been lithiated in the 8-position and subsequently brominated when trapped with BrCCl2CCl2Br. The 8-bromopurines were isolated in excellent yields when the benzyl group carried an alkoxy or alkyl group in the ortho or para position. Without these substituents, the conversion was generally less, and formation of 8,8'-purinyl dimers was observed. There was also evidence of debenzylation in some instances. Bromination of 7-benzylpurines employing the same set of reaction conditions has also been achieved.
• KELLEY, JAMES L.;KROCHMAL, MARK P.;LINN, JAMES A.;MCJEAN, ED W.;SOROKO, F+, J. MED. CHEM., 31,(1988) N 3, 606-612
  作者：KELLEY, JAMES L.、KROCHMAL, MARK P.、LINN, JAMES A.、MCJEAN, ED W.、SOROKO, F+

  DOI：——

  日期：——